ACAT INHIBITORS AS ANTIATHEROSCLEROTIC AGENTS - COMPOUNDS AND MECHANISMS

被引：149

作者：

MATSUDA, K

机构：

[1] Cardiovascular & Atherosclerosis Research Laboratories, Yamanouchi Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co. Ltd, Tsukuba, Ibaraki, 305, 21, Miyukigaoka

来源：

MEDICINAL RESEARCH REVIEWS | 1994年 / 14卷 / 03期

关键词：

D O I：

10.1002/med.2610140302

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：271 / 305

页数：35

共 108 条

[1]

ADELMAN SJ, 1992, 11TH INT S DRUGS AFF, P114

[2] CETABEN SODIUM, AN ANTI-ATHEROSCLEROTIC AGENT [J].

ALBRIGHT, JD ;

SCHAFFER, SA ;

SHEPHERD, RG .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (07) :936-937

[3] POTENTIAL ANTI-ATHEROSCLEROTIC AGENTS .2. (ARALKYLAMINO)BENZOIC AND (ALKYLAMINO)BENZOIC ACID ANALOGS OF CETABEN [J].

ALBRIGHT, JD ;

DEVRIES, VG ;

LARGIS, EE ;

MINER, TG ;

REICH, MF ;

SCHAFFER, SA ;

SHEPHERD, RG ;

UPESLACIS, J .

JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (10) :1378-1393

[4]

ARROWSMITH RJ, 1991, 9TH INT S ATH ROS US, V185, P99

[5]

ASHTON MJ, 1991, 9TH INT S ATH ROS US, V185, P100

[6] DEGRADATION OF CATIONIZED LOW-DENSITY LIPOPROTEIN AND REGULATION OF CHOLESTEROL-METABOLISM IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA FIBROBLASTS [J].

BASU, SK ;

GOLDSTEIN, JL ;

ANDERSON, RGW ;

BROWN, MS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (09) :3178-3182

[7]

BELL FP, 1991, 9TH INT S ATH ROS US, V184, P95

[8]

BILLHEIMER JT, 1991, 9TH INT S ATH ROS US, V184, P94

[9] BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].

BLANKENHORN, DH ;

NESSIM, SA ;

JOHNSON, RL ;

SANMARCO, ME ;

AZEN, SP ;

CASHINHEMPHILL, L .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240

[10] CURRENT THERAPY FOR HYPERCHOLESTEROLEMIA [J].

BLUM, CB ;

LEVY, RI .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (24) :3582-3587

← 1 2 3 4 5 6 7 8 9 10 →